Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 143

Sort by

Sort Order Select

Journal Articles

The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1

Blood (2020) 136 (8): 957–973.

https://doi.org/10.1182/blood.2019002548

Published: 2020

Includes: Supplemental data

Journal Articles

Aberrant RNA Splicing Contributes to the Pathogenesis of EVI-Rearranged Myeloid Leukemias

Daichi Inoue, MD PhD, Stanley C Lee, PhD, Akihide Yoshimi, MD PhD, Justin Taylor, MD, Lillian E Bitner, BSc, Atsushi Tanaka, MD, Yasutaka Hayashi, MD PhD, Hana Cho, MSc, Chie Fukui, Ruth Saganty, Alexander V Penson, PhD, Omar Abdel-Wahab, MD

Blood (2019) 134 (Supplement_1): 917.

https://doi.org/10.1182/blood-2019-124722

Published: 2019

Journal Articles

CYT-0853, a Novel RAD51 Inhibitor, Modulates Immunoregulatory B-Lymphocytes

Tamar Aprahamian, PhD, ED Keniston, Jane Branca, Muneer G Hasham, PhD, Melinda Day, PhD, Kevin Mills, PhD

Blood (2019) 134 (Supplement_1): 2330.

https://doi.org/10.1182/blood-2019-131311

Published: 2019

Journal Articles

Understanding Erythropoiesis Using Quantitative Proteomics and Single Cell Mass Cytometry

Marjorie Brand, PhD

Blood (2019) 134 (Supplement_1): SCI-21.

https://doi.org/10.1182/blood-2019-121109

Published: 2019

Journal Articles

Overexpression or Deficiency of RUNX3 Results in Defective Normal Human Hematopoietic Development Similar to RUNX1-ETO Expression in AML

Ana Catarina Menezes, MSc, BSc, Steven Knapper, DM, Richard L Darley, PhD, Alex Tonks, PhD

Blood (2019) 134 (Supplement_1): 2527.

https://doi.org/10.1182/blood-2019-130798

Published: 2019

Journal Articles

Reprogramming Leukemia Cells into Antigen Presenting Cells As a Novel Cancer Vaccination Immunotherapy

Miles Hamilton Linde, BS, BA, Christopher G Dove, Sarah F Gurev, Paul Phan, Feifei Zhao, MD, Lindsay P Miller, Ravindra Majeti, MD PhD

Blood (2019) 134 (Supplement_1): 3217.

https://doi.org/10.1182/blood-2019-128577

Published: 2019

Journal Articles

Activation of Hottip lncrna Perturbs HSC Function Leading to AML like Disease in Mice

Huacheng Luo, Ganqian Zhu, PhD, Jie Zha, MD, Bowen Yan, Ph. D, Ying Guo, Jianfeng Xu, PhD, Qian Lai, Bing Xu, MD PhD, Feng-Chun Yang, MD PhD, Wei Li, Yi Qiu, Mingjiang Xu, MD PhD, Suming Huang

Blood (2018) 132 (Supplement 1): 3877.

https://doi.org/10.1182/blood-2018-99-110218

Published: 2018

Journal Articles

Efficient Gene Transduction and Reprogramming of Hematopoietic Cells Including T-Cells By Using a Non-Integrating Measles Virus Vector

Jiyuan Liao, PhD, Yasushi Soda, MD PhD, Ai Sugawara, B.Sc., Yoshie Miura, PhD, Takafumi Hiramoto, PhD, Maino Tahara, PhD, Yuto Takishima, M.S., Lisa Hirose, Yasuki Hijikata, MD PhD, Shohei Miyamoto, PhD, Makoto Takeda, MD PhD, Kenzaburo Tani, MD PhD

Blood (2018) 132 (Supplement 1): 3494.

https://doi.org/10.1182/blood-2018-99-120350

Published: 2018

Journal Articles

Mutational Landscape and Temporal Evolution during Treatment of Relapsed Acute Lymphoblastic Leukemia

Blood (2018) 132 (Supplement 1): 917.

https://doi.org/10.1182/blood-2018-99-119144

Published: 2018

Journal Articles

BET Inhibitors Potentiate Activation of p53 and Killing of AML By MDM2 Inhibitors — a Candidate Combination Therapy

Peter D Adams, Anne Louise Latif, Ashley Newcombe, Neil Robertson, Maria Terradas, Helen Stewart, Claire Reid, Loveena Rishi Delori, Timothy Chevassut, Xu Huang, BSc, PhD, Karen Keeshan, Karen Blyth, Mhairi Copland

Blood (2018) 132 (Supplement 1): 3912.

https://doi.org/10.1182/blood-2018-99-115509

Published: 2018

Journal Articles

Nfix Â Promotes Survival of Immature Hematopoietic Cells Via Regulation of C-Mpl

Trent Hall, BS, MS, Megan Walker, BS, MS, Miguel Ganuza Fernandez, PhD, Per Holmfeldt, PhD, Marie Bordas, Guolian Kang, PhD, Wenjian Bi, PhD, Lance Palmer, PhD, David Finkelstein, PhD, Shannon McKinney-Freeman, PhD

Blood (2017) 130 (Supplement 1): 2423.

https://doi.org/10.1182/blood.V130.Suppl_1.2423.2423

Published: 2017

Journal Articles

Molecular Determinants for Polycomb Group Protein YY1 Control of Hematopoietic Stem Cell Quiescence

Zhanping Lu, PhD, Courtney Hong, Guangyao Kong, PhD, Anna L F. V. Assumpção, Irene Ong, Emery H Bresnick, PhD, Jing Zhang, PhD, Xuan Pan, PhD DVM

Blood (2017) 130 (Supplement 1): 1140.

https://doi.org/10.1182/blood.V130.Suppl_1.1140.1140

Published: 2017

Journal Articles

PRMT5 Regulates DNA Repair By Controlling the Alternative Splicing of Epigenetic Factors

Pierre-Jacques Hamard, PhD, Gabriel Emmanuel Santiago, Fan Liu, PhD, Sarah Greenblatt, PhD, Daniel Karl, PhD, Concepcion Martinez, B.S., Ramiro E Verdun, PhD, Stephen D. Nimer, MD

Blood (2017) 130 (Supplement 1): 1148.

https://doi.org/10.1182/blood.V130.Suppl_1.1148.1148

Published: 2017

Journal Articles

MiR- 16 Regulates Crosstalk in NF-κB Inflammatory Signaling between Myeloma Cells and Bone Marrow Macrophages

Jihane Khalife, Domenico Viola, BS, Jayeeta Ghose, Robert Weingart, James F Sanchez, Craig C Hofmeister, MDMPH, Amrita Krishnan, MD, Guido Marcucci, MD, Nadia Carlesso, MD PhD, Enrico Caserta, PhD, Flavia Pichiorri, PhD

Blood (2017) 130 (Supplement 1): 4351.

https://doi.org/10.1182/blood.V130.Suppl_1.4351.4351

Published: 2017

Journal Articles

SCL/TAL1: a multifaceted regulator from blood development to disease

Catherine Porcher, Hedia Chagraoui, Maiken S. Kristiansen

Blood (2017) 129 (15): 2051–2060.

https://doi.org/10.1182/blood-2016-12-754051

Published: 2017

Journal Articles

Peptidomimetic Blockade of MYB in Acute Myeloid Leukemia

Kavitha Ramaswamy, MD, Lauren Forbes, Fiona C Brown, PhD, Richard Koche, PhD, Tatyana Gindin, MDPhD, Gerard Minuesa, PhD, Michael G. Kharas, PhD, Andrei Krivtsov, PhD, Scott A. Armstrong, MD PhD, Eric Still, Elisa de Stanchina, PhD, Randi Isenhart, Guangwu Guo, Birgit Knoechel, MDPhD, Alex Kentsis, MD PhD

Blood (2016) 128 (22): 3945.

https://doi.org/10.1182/blood.V128.22.3945.3945

Published: 2016

Journal Articles

Efficient Site-Specific Multi-Gene Engineering of Renewable Pluripotent Cells for Generation of Off-the-Shelf Hematopoietic Immunotherapeutics

Ramzey Abujarour, PhD, Weijie Lan, PhD, Tom Tong Lee, PhD, Greg Bonello, Miguel Meza, MS, Megan Robinson, BS, Raedun Clarke, PhD, Christopher Truong, Chris Lynn, BS, David Robbins, BS, Betsy Rezner, BS, Stewart E. Abbot, PhD BSc, MSc, Daniel Shoemaker, PhD, Bahram Valamehr, PhD MBA

Blood (2016) 128 (22): 5887.

https://doi.org/10.1182/blood.V128.22.5887.5887

Published: 2016

Journal Articles

NR4A3 Suppresses Lymphomagenesis I n Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1

Alexander JA Deutsch, PhD, Beate Rinner, Martin Pichler, Karoline Fechter, Hildegard T. Greinix, MD, Chenguang Wang, Christine Beham-Schmid, MD, Peter Neumeister, MD

Blood (2016) 128 (22): 2728.

https://doi.org/10.1182/blood.V128.22.2728.2728

Published: 2016

Journal Articles

Alox5 Functions As Both Tumor Suppressor and Drug Sensitizer in AML

Xi Jiang, PhD, Yungui Wang, PhD, Chao Hu, PhD, Jennifer Strong, Lei Dong, PhD, Rui Su, PhD, Hengyou Weng, PhD, Huilin Huang, PhD, Chenying Li, Jie Jin, MD PhD, Jianjun Chen, PhD

Blood (2016) 128 (22): 2851.

https://doi.org/10.1182/blood.V128.22.2851.2851

Published: 2016

Journal Articles

HB9 Represses Hematopoietic Stem Cell Proliferation and Induces Senescence

Deborah Ingenhag, MSc, Franziska Auer, MSc, Arndt Borkhardt, MD, Julia Hauer, MD

Blood (2016) 128 (22): 1539.

https://doi.org/10.1182/blood.V128.22.1539.1539

Published: 2016

NARROW

The EMT modulator SNAI1 contributes to AML pathogenesis via its interaction with LSD1

Aberrant RNA Splicing Contributes to the Pathogenesis of EVI-Rearranged Myeloid Leukemias

CYT-0853, a Novel RAD51 Inhibitor, Modulates Immunoregulatory B-Lymphocytes

Understanding Erythropoiesis Using Quantitative Proteomics and Single Cell Mass Cytometry

Overexpression or Deficiency of RUNX3 Results in Defective Normal Human Hematopoietic Development Similar to RUNX1-ETO Expression in AML

Reprogramming Leukemia Cells into Antigen Presenting Cells As a Novel Cancer Vaccination Immunotherapy

Activation of Hottip lncrna Perturbs HSC Function Leading to AML like Disease in Mice

Efficient Gene Transduction and Reprogramming of Hematopoietic Cells Including T-Cells By Using a Non-Integrating Measles Virus Vector

Mutational Landscape and Temporal Evolution during Treatment of Relapsed Acute Lymphoblastic Leukemia

BET Inhibitors Potentiate Activation of p53 and Killing of AML By MDM2 Inhibitors — a Candidate Combination Therapy

Nfix Â Promotes Survival of Immature Hematopoietic Cells Via Regulation of C-Mpl

Molecular Determinants for Polycomb Group Protein YY1 Control of Hematopoietic Stem Cell Quiescence

PRMT5 Regulates DNA Repair By Controlling the Alternative Splicing of Epigenetic Factors

MiR- 16 Regulates Crosstalk in NF-κB Inflammatory Signaling between Myeloma Cells and Bone Marrow Macrophages

SCL/TAL1: a multifaceted regulator from blood development to disease

Peptidomimetic Blockade of MYB in Acute Myeloid Leukemia

Efficient Site-Specific Multi-Gene Engineering of Renewable Pluripotent Cells for Generation of Off-the-Shelf Hematopoietic Immunotherapeutics

NR4A3 Suppresses Lymphomagenesis I n Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1

Alox5 Functions As Both Tumor Suppressor and Drug Sensitizer in AML

HB9 Represses Hematopoietic Stem Cell Proliferation and Induces Senescence

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only